Jinhe Biotechnology CO., LTD. (SHE:002688)
6.28
+0.08 (1.29%)
Apr 29, 2025, 2:45 PM CST
SHE:002688 Revenue
Jinhe Biotechnology CO., LTD. had revenue of 625.15M CNY in the quarter ending March 31, 2025, with 20.35% growth. This brings the company's revenue in the last twelve months to 2.48B, up 14.31% year-over-year. In the year 2024, Jinhe Biotechnology CO., LTD. had annual revenue of 2.37B with 9.04% growth.
Revenue (ttm)
2.48B
Revenue Growth
+14.31%
P/S Ratio
1.89
Revenue / Employee
1.07M
Employees
2,316
Market Cap
4.69B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.37B | 196.50M | 9.04% |
Dec 31, 2023 | 2.17B | 51.43M | 2.42% |
Jan 1, 2023 | 2.12B | 44.72M | 2.15% |
Jan 1, 2022 | 2.08B | 263.35M | 14.51% |
Dec 31, 2020 | 1.81B | 32.27M | 1.81% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
WuXi AppTec | 37.92B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.79B |
Aier Eye Hospital Group | 20.98B |
Sichuan Biokin Pharmaceutical | 5.82B |
Shanghai United Imaging Healthcare | 10.30B |
Yunnan Baiyao Group Co.,Ltd | 40.03B |